ChargePoint Technology Industry Blog

An Industry Review of 2017 - Part 2

19 December 2017

Looking back at 2017...

As the year draws to a close, we have reached a natural point of reflection here at ChargePoint. 2017 has been yet another significant year for the pharmaceutical industry, which is experiencing a notable period of change. The last few years have seen the industry begin to transform; with the growing use of data and technology, increasing development of high potency products, the enforcement of serilisation regulations in the US, and an ever increasing move towards single-use technology. Importantly for ChargePoint, the biopharma boom continues and therefore the demand for containment, particularly from therapeutic areas such as oncology and hormonal drug products, continues to grow.

An Industry Review of 2017 - Part 1

19 December 2017

Looking back at 2017...

As the year draws to a close, we have reached a natural point of reflection here at ChargePoint. 2017 has been yet another significant year for the pharmaceutical industry, which is experiencing a notable period of change. The last few years have seen the industry begin to transform; with the growing use of data and technology, increasing development of high potency products, the enforcement of serilisation regulations in the US, and an ever increasing move towards single-use technology. Importantly for ChargePoint, the biopharma boom continues and therefore the demand for containment, particularly from therapeutic areas such as oncology and hormonal drug products, continues to grow.

Discussing the growing need for high potency handling capabilities

28 September 2017
By ChargePoint

Demand for high potent active pharmaceutical ingredients is driving the need for high potency handling capabilities.

In this latest article with EPM Magazine, ChargePoint Technology's Global Product Manager for Containment, Mike Avraam, discusses this growing sector in detail and how the need for change in manufacturing facilities has changed over the last 10 years.

Preventing Contamination During Sterile Powder Transfer

11 April 2017

Find out the results of our latest testing to qualify Chlorine Dioxide (CD) gas as an alternative to H202 for decontamination in our AseptiSafe Bio valve.

Aseptic Manufacturing Trends & Challenges

11 April 2017

Christian Dunne, Global Product Manager for AseptiSafe at ChargePoint joined leaders from Recipharm and Symbiosis Pharmaceutical Services to address key trends and challenges in the Aseptic manufacturing market.



Subscribe to RSS Feed